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Background: Cullin ubiquitin ligases are activated via the covalent modification of Cullins by the small
ubiquitin-like protein nedd8 in a process called neddylation. Genetic mutations of cullin-4b (cul4b) cause a prevalent
type of X-linked intellectual disability (XLID) in males, but the physiological function of Cul4B in neuronal cells
remains unclear.
Results: There are three major isoforms of Cul4B (1, 2, and 3) in human and rodent tissues. By examining the
endogenous Cul4B isoforms in the brain, this study demonstrates that Cul4B-1 and Cul4B-2 isoforms are
unneddylated and more abundant in the brain whereas the lesser species Cul4B-3 that misses the N-terminus
present in the other two isoforms is neddylated. The data suggest that the N-terminus of Cul4B inhibits neddylation
in the larger isoforms. Immunostaining of human NT-2 cells also shows that most Cul4B is unneddylated, especially
when it is localized in the process in G0-synchronized cells. This study demonstrates that Cul4B accumulates during
mitosis and downregulation of Cul4B arrests NPCs and NT-2 cells in the G2/M phase of the cell cycle. In both
human and rodent brain tissues, Cul4B-positive cells accumulate β-catenin in the dentate subgranular zone and the
subventricular zone. These Cul4B-positive cells also co-express the MPM-2 mitotic epitope, suggesting that Cul4B is
also necessary for mitosis progression in vivo.
Conclusions: This study provides first evidence that unneddylated Cul4B isoforms exist in the brain and are
necessary for mitosis progression in NPCs. The data suggest that unneddylated Cul4B isoforms specifically inhibits
β-catenin degradation during mitosis. Furthermore, unneddylated Cul4B may play a role in addition to cell cycle
since it is exclusively localized to the processes in starved NT-2 cells. Further analyses of the different isoforms of
Cul4B will help understand the cognitive deficits in Cul4B-linked XLID and give insights into drug and biomarker
discoveries.
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Ubiquitin ligases control the modification of proteins
with ubiquitin by interacting with specific substrates.
They play critical roles in neuronal functions and
homeostasis. For example, mutations of the ubiquitin
ligase Ube3A cause Angelman syndrome [1,2]. Ube3A
regulates the degradation of Arc, a synaptic protein that
promotes the internalization of the AMPA subtype of
glutamate receptors [3]. Another example is that the
ubiquitin ligase Parkin is mutated in early onset Parkin-
son’s disease [4]. Parkin is involved in the clearance of* Correspondence: chenyuzhi@uams.edu
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reproduction in any medium, provided the ordamaged mitochondria [5]. It has been shown recently
that mutations of another ubiquitin ligase cullin-4b
(cul4b) in the X chromosome cause X-linked intellectual
disability (XLID) in males [6-8]. Genetic mutations of
cul4b account for about 3% of the XLID population,
which places cul4b as one of the most commonly
mutated genes underlying XLID [8]. Such cul4b muta-
tions include large C-terminal truncations and missense
mutations in or near the Cullin domain that may impair
or nullify Cul4B ubiquitin ligase activity [7,8]. Intellec-
tual disability is a consistent feature associated with
Cul4B-XLID, but the physiological function of Cul4B in
neuronal cells or neurodevelopment remains to be
determined.
Cul4B belongs to the family of Cullin-RING ubiquitin
ligases (CRLs), in which the Cullin serves as the scaffold-
ing protein in the modular CRLs [9]. Cullins areThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in a conserved lysine residue in the C-terminus that also
binds to a RING (really interesting gene) protein Rbx1 or
Rbx2 [10,11]. Neddylation of Cullins activates CRLs by
inducing a conformational change that promotes ubiqui-
tin transfer to the substrate for ubiquitination [12-14].
The N-terminus of Cullins interacts with Cullin-specific
substrate receptor subunits usually via adaptor proteins
[9,15]. Cullin neddylation depends on the assembly of
the CRL complex including the RING protein and the
substrates. Besides neddylation that activates CRLs, the
COP9 signalosome (COP9) and CAND1 also positively
regulate CRL activity [15-17]. Another regulator ASPP2
inhibits Cullin neddylation and opposes APP-BP1-
mediated cell cycle progression [10,18].
Among the seven Cullins identified, Cul4A and Cul4B
are derived from the same ancestral Cul4. There is 83%
identity between human Cul4A and Cul4B. Cul4B is
present only in mammals and differs from Cul4A mainly
by an amino terminal extension that may confer Cul4B-
specificity. The architecture of Cul4s looks similar, with
both binding to Rbx1 and the adaptor protein DNA
damage-binding protein-1 (DDB1) [19]. DDB1 binds to
a substrate-specific WD-repeat-containing protein [19].
Cul4A is necessary for embryonic development since
Cul4A knockout mice are embryonic lethal [20]. How-
ever, the lethality was questioned since a second line of
Cul4A mutant mice that delete exons 17-19 that encode
the Rbx1 binding site and the neddylation site in the
cul4a gene, produces viable mice due. The lethality of
the first strain may be caused by the unintentional dele-
tion of a region upstream of the first exon of the essen-
tial Psid2 gene in the Cul4A mutant mice [21].
The functional analyses of Cul4B are hindered by the
lack of a knockout animal model, but available data in
literature suggest that Cul4B plays significant roles in
many aspects of cellular functions. Like Cul4A, Cul4B
also ubiquitinates histone H2A, H3, and H4, facilitating
the recruitment of repair proteins to the damaged DNA
[22,23]. Cul4B mutant carrier-derived cells are impaired
in camptothecin-induced topoisomerase I degradation
and ubiquitination [24]. Cul4B has also been shown to
regulate dioxin-dependent receptor signaling [25]. In
addition, Cul4B downregulates cyclin E [26,27] and β-
catenin [28,29]. Cul4B suppression increases β-catenin
levels in rodent cells [29]. Cul4B accumulates in the nu-
cleus during cell differentiation [28]. More recently,
Cul4B has been shown to downregulate WDR5 [30] and
Peroxiredoxin III [31].
Motivated by the recent discoveries that Cul4B muta-
tions cause XLID, we analyzed Cul4B functions in
neuronal tissues in vivo and in vitro. We found that
unneddylated Cul4B isoforms accumulated during mi-
tosis of the cell cycle in neural progenitor cells (NPCs).Downregulation of Cul4B by shRNAs arrested the cell
cycle in the G2/M phase in NPCs and in human NT-2
cells. NPCs that strongly expressed Cul4B were found
in the subventricular zone (SVZ) and the subgranular
zone (SGZ) in both mouse and human brain tissues.
Such Cul4B-positive cells co-expressed high levels of β-
catenin in vivo. Furthermore, these Cul4B-expressing
NPCs were not apoptotic based on TUNEL staining
and flow cytometric analyses. Taken together, these
data suggest that the accumulation of unneddylated
Cul4B is necessary for mitosis progression in NPCs.
Results
Cul4B expression in rodent brain extracts by
immunoprecipitation-western blotting
The rabbit anti-Cul4B antibody obtained from Protein-
tech was raised against Cul4B(1-350), which consisted of
Cul4A homologous sequences that might lead to cross-
reactions with Cul4A (personal communications with
Proteintech). To determine the specificity of this anti-
Cul4B antibody, NPCs were transfected with GFP or
GFP-tagged N-terminal 173 amino acids of Cul4B
(GFP173). The whole cell lysate was probed with either
the anti-Cul4B or mouse anti-GFP. As shown in
Figure 1A, the Cul4B antibody specifically recognized
GFP173 (left), whereas the anti-GFP antibody recognized
both GFP173 and GFP (right). A minor band around 60
amino-acid longer than GFP was also found in the
GFP173-expressing cells as indicated by a *, which sug-
gests that Cul4B might be cleaved near the nuclear
localization signal on the N-terminus [27].
The C-terminal Cul4B has the consensus neddylation
site and has been shown to be neddylated in vitro
[32,33]. Neddylation of Cullins may serve as a switch for
a conformational change that leads to the activation of
ubiquitination by CRLs. To determine if Cul4B was ned-
dylated, adult mouse brain protein extracts were immu-
noprecipitated with the anti-Cul4B antibody. The blot
was first probed with the anti-nedd8 antibody. Rat and
mouse Cul4Bs have three major isoforms due to alterna-
tive splicing based on the sequences from the Uni-
ProtKB/Swiss-Prot data base. The calculated molecular
weights (MWs) of mouse Cul4Bs were 111 (Cul4B-1),
107 (Cul4B-2), and 87 kDa (Cul4B-3). Compared to
Cul4B-1, Cul4B-3 missed the first 187 amino acids
whereas Cul4B-2 missed amino acids 693-721. As shown
in Figure 1B (left), the band recognized by the anti-
nedd8 antibody was likely to be Cul4B-3. The rabbit
anti-nedd8 antibody used in the blots was the best anti-
nedd8 and is commonly used by other researchers.
To determine if the anti-Cul4B immunoprecipitation
experiment worked, the blot was stripped and reprobed
with the anti-Cul4B antibody. The major immunopreci-
pitated band corresponded to Cul4B-2 since it migrated
Figure 1 The anti-Cul4B antibody mainly recognized the larger, unneddylated Cul4B isoforms, Cul4B-1 and Cul4B-2. A. Cul4B antibody
specifically recognized a Cul4B fusion protein. Protein extracts from NPCs transfected with a construct consisting of Cul4B N-terminal 173 amino
acids fused to GFP (GFP173). Left, The anti-Cul4B antibody recognized the Cul4B fragment GFP173. Right, GFP173 was confirmed by the anti-GFP
blot. The * indicates the band of cleaved N-terminal GFP173. B. Analyses of Cul4B neddylation by immunoprecipitation-western using mouse brain
extracts. Cul4B was immunoprecipiated with the rabbit anti-Cul4B antibody prebound to protein A-agarose. The negative control was
immunoprecipitation with protein A-agarose without antibodies. Left, The blot was first probed with a rabbit anti-nedd8 antibody. A smaller band
corresponding to the size of Cul4B-3 was neddylated. Right, The blot was stripped and reprobed with the Cul4B antibody. The major band
corresponds to the MW of Cul4B-2. A minor band of higher MW corresponds to Cul4B-1. Cul4B-3 is also vaguely present. n= 3. C. The Cul4B
antibody did not recognize Cul4A or Cul1. Cul4B was immunoprecipitated from mouse brain protein extracts as in B in triplicates. The blots were
blotted with the anti-Cul4B, anti-Cul4A, or anti-Cul1 antibodies. The results show that the neddylated band in B was not Cul4A or Cul1. The
results also showed that the Cul1 and Cul4A antibodies cross-reacted with Cul4B-2. The Cul4A and Cul1 bands in C are indicated by a *. D. The
anti-Cul4B precipitates RBX1 in NT-2 cell extracts (n= 2) and DDB1 in mouse brain extracts. (n = 3).
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minor upper band corresponding to Cul4B-1 was also
detected by the Cul4B antibody. However, as shown by
the nedd8 blot, Cul4B-1 and -2 were not neddylated
since the anti-nedd8 antibody did not recognized these
bands (Figure 1B, left).
The nedd8-positive lower band precipitated by the
anti-Cul4B antibody was further evaluated with anti-
bodies against Cul4A and Cul1. In this experiment, the
immuno-precipitates were analyzed in triplicates by blot-
ting with the anti-Cul4B, anti-Cul4A, and anti-Cul1 anti-
bodies, respectively (Figure 1C). The results showed that
the anti-Cul4A or anti-Cul1 antibodies recognized a
band corresponding to the molecular weights of Cul4A
and Cul1, respectively, in the whole brain extract, but
they did not recognize the neddylated lower band in the
Cul4B precipitate as identified in Figure 1B (left). These
experiments also showed that the anti-Cul4A and anti-
Cul1 antibodies cross-reacted with Cul4B since they
recognized the immunoprecipitated Cul4B-2. The results
suggest that the lower neddylated band identified in
Figure 1B (left) was not Cul4A or Cul1. Thus, the ned-
dylated band was likely to be Cul4B-3. Cul4B-1 and
Cul4B-2 appeared to be the major species in the brain as
shown in the whole brain extract, but the antibody pre-
cipitated more Cul4B-2. Cul4B-3 might be the leastabundant since the anti-Cul4B antibody did not
recognize this isoform in the whole brain extract. How-
ever, the efficiency of the anti-Cul4B in recognizing
Cul4B-3 might be less since this isoform missed the first
187 amino acids of Cul4B-1 and 2, which was part of the
antigen. Nonetheless, these data demonstrated that the
anti-Cul4B in use mainly recognized Cul4B, especially
Cul4B-1 and Cul4B-2, but not other Cullins. The data
also showed that the larger Cul4B isoforms were
unneddylated.
We next examined if the anti-Cul4B antibody would
also bring down the ligase adaptors. The antibody precipi-
tated RBX1 in NT-2 cells and DDB1 from mouse brain
homogenate (Figure 1D). RBX1 was very abundant in NT-
2 cells. Since the level of DDB1 in whole brain lysate was
below the detection limit, the anti-DDB1 immunoprecipi-
tate was used as a positive control. DDB1 appeared to be a
limiting factor and the amount co-precipitated by the
Cul4B antibody was less than that precipitated by the
DDB1 antibody, suggesting that only some Cul4B (prob-
ably only Cul4B-3) was bound to DDB1.
Cul4B was not neddylated in vitro or in vivo as shown by
immunostaining
The above experiments suggest that the anti-Cul4B
mainly recognized unneddylated Cul4B isoforms in brain
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teins are present in the nucleus of normal neuronal
cells [34]. Cul4B sequences are highly conserved among
mammalian species. Like rodent cells, human cells also
have three major isoforms of Cul4B according to Uni-
ProtKB/Swiss-Prot data base. In human cells, compared
to the canonical Cul4B-1 that has 913 amino acids,
Cul4B-2 misses the first 22 amino acids and Cul4B-3
misses the first 196 amino acids and differs in amino
acids 197-203. To determine if the anti-Cul4B mainly
recognized unneddylated Cul4B, human NT-2 cells
were immunostained with the rabbit anti-Cul4B and
the mouse anti-nedd8 antibodies. In the metaphase cell,
most Cul4B did not co-localize with nedd8 (Figure 2A,
top). In this cell, Cul4B was present in the periphery
whereas nedd8 accumulated around the condensed
DNA. In old NT-2 cells with extended processes that
suggested cell differentiation, the processes often had
Cul4B especially at the process tip, but such Cul4B was
not neddylated (Figure 2A, middle). In G0-
synchronized NT-2 cells, nedd8 accumulated in the nu-
cleus whereas Cul4B was still in the process tip
(Figure 2A, bottom). In contrast to Cul4B, Cul1 wasFigure 2 Cul4B did not colocalize with nedd8. A. Cul4Bs were not nedd
most Cul4Bs did not co-localize with nedd8. The middle role shows a cell f
not neddylated. The bottom row shows G0-synchronized NT-2 cells in whi
cells also had unneddylated Cul4Bs in processes. The space bars represent 5
nucleus in G0-synchronized NT2 cells. The space bar is 5 μm. C. Cul4Bs did
stained with the anti-Cul4B and mouse anti-nedd8. The image was taken n
observed and appeared to represent neddylated Cul4B-3. A huge amount
accessible by DAPI. The space bar is 10 μm. All images were obtained with apresent in the nucleus in G0-synchronized NT-2 cells
(Figure 2B).
To determine if Cul4B and nedd8 colocalized in vivo,
human hippocampal brain sections were immunos-
tained with the anti-Cul4B and the mouse anti-nedd8
antibodies (Figure 2C). Smaller cells and the ependymal
cells along the ventricle were clearly labeled by the
nedd8 antibody. However, the Cul4B-positive cells
expressed little nedd8. A tiny amount of punctate
nedd8 staining was present in the Cul4B-positive cells,
which might represent neddylated Cul4B-3, but it was
almost negligible compared to the huge amount of
unneddylated Cul4B (Figure 2C). The huge amount of
Cul4B appeared to inhibit DAPI staining of the DNA
in these cells.
To summarize, the data showed that the anti-Cul4B
specifically recognized Cul4B but not other Cullins. This
antibody mainly recognized unneddylated Cul4B-1 and
Cul4B-2 that accumulated in NPCs or NT-2 cells. Since
all isoforms of Cul4B have the C-terminal neddylation
consensus site, the data suggest that the presence of the
extended N-terminus in Cul4B-1 and Cul4B-2 but miss-
ing in Cul4B-3 may inhibit neddylation.ylated in NT-2 cells. The top row shows a metaphase cell in which
rom an old NT-2 that had a Cul4B-positive process where Cul4B was
ch nedd8 was induced by synchronization in 0.02% FBS for 48 h. These
, 5, and 10 μm, respectively. B. Cul1 and nedd8 were detected in the
not colocalize with nedd8 in vivo. Human brain hippocampus was
ear SVZ. A tiny amount of punctate nedd8 (white arrows) was also
of unneddylated Cul4B was found in some cells that had DNA less
40x objective.
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NPCs
We have previously demonstrated our ability to grow
primary NPCs that express nestin and Ki67 from E18 rat
cortices [35]. Taking advantage of these primary cul-
tures, we first determined the expression pattern of
Cul4B during the cell cycle. Only a small fraction of
NPCs expressed Cul4B in a given NPC culture
(Figure 3A). These Cul4B-positive cells were also nestin-
positive, but unlike the other nestin-positive cells, they
appeared to have retracted their processes, a feature of
cells undergoing mitosis. We then examined the expres-
sion of Cul4B during the cell cycle. Based on the distinct
morphologies of the DNA in the cell cycle, Cul4B wasFigure 3 Cul4B accumulated during mitosis of the cell cycle in neural
NPCs were found in rat NPC cultures. x20 objective; scale bars, 4 μm. B. Cul4
objective; scale bars, 2 μm. An analyses of Cul4B density in NPCs during inte
two-tail t-Test). Y-axis, Cul4B levels in arbitrary units. C. NPCs undergoing DN
synthesis was identified by pulse-BrdU labeling right before fixation. x60 ob
labeling. A comparison of BrdU-positive (BrdU+) versus BrdU-negative (BrdU
negative cells than in BrdU-positive cells (p= 0.00016, two-tail t-Test). Y-axisexpressed mainly during mitosis in NPCs (Figure 3B).
Cul4B began to accumulate at the beginning of mitosis
and it disappeared after cytokinesis. The analyses of
Cul4B levels also showed that Cul4B levels were signifi-
cantly higher during mitosis than during interphase in
NPCs (Figure 3B, right).
To further confirm that Cul4B was absent in inter-
phase cells, NPCs were pulse-labeled with BrdU to iden-
tify the cells undergoing DNA synthesis. In this
experiment, NPCs were exposed to BrdU for 15 min and
fixed right after the labeling. The brief treatment with
BrdU ensured that only those NPCs undergoing S-phase
DNA synthesis would incorporated BrdU. Longer expos-
ure with BrdU would label cells at the other stages ofprogenitor cells (NPCs) in vitro. A. Cul4B and nestin double-positive
B accumulated only during mitosis of the cell cycle in rat NPCs. x60
rphase versus mitosis revealed a significant difference (p = 5× 10-10,
A synthesis (green) did not express Cul4B. Cells undergoing DNA
jective; scale bars, 2 μm. D. Mouse NPCs were analyzed after BrdU
-) cells shows that Cul4B levels were significantly higher in BrdU-
, Cul4B levels in arbitrary units.
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showed that Cul4B was not present in the BrdU-labeled
S-phase cells in rat primary NPCs (Figure 3C). Similar
BrdU-labeling was performed in NPCs isolated from
Day-0 newborn mouse cortices. The analyses showed
that BrdU-positive S-phase cells had significantly lower
levels of Cul4B than BrdU-negative cells (Figure 3D).
These data suggest that Cul4B plays a specific role in
the progression of mitosis.
Downregulation of Cul4B arrested NPCs in the G2/M
phase of the cell cycle
To examine the function of Cul4B during mitosis, a
Cul4BshRNA vector was constructed to downregulate
Cul4B expression. The selected targeting sequence
(GATAAGCCTAAATTACCAGAA) was previously
tested by another laboratory [36]. This sequence is
present in all three isoforms of Cul4B. The expression of
shRNAs is under the control of the tRNAval promoter
[37,38]. A GFP open-reading frame under the CMV pro-
moter is also present in this vector. When packaged into
HSV-1, the Cul4BshRNA vector efficiently downregu-
lated Cul4B in NT-2 cells compared to the controlFigure 4 Downregulation of Cul4B in NPCs or NT-2 cells led to cell cy
shRNAs via HSV-1 vector suppressed Cul4B levels in NT-2 cells. The control
expression in rat NPCs. NPCs transfected with the control vector or the Cul
collected in the same settings. Analyses of GFP-positive cells showed that C
Density of Cul4B fluorescence is presented in the bar graph (Y-axis, arbitrar
downregulation by shRNAs arrested the cell cycle at the G2/M phase in NP
or the vector that had Cul4BshRNA. The graph represented data analyses fr
in the G2/M phase, two tail t-Test, p = 0.03. D. A representative histogram of
HSV-1 vector increased the number of cells in the G2/M phase of the cell c
apoptotic cells (sub) was found due to Cul4BshRNA expression in either NTmissense shRNA (Figure 4A). This suggests that the
Cul4B shRNA effectively suppressed the expression of
total Cul4B.
The effect of the Cul4BshRNA vector in downregu-
lating Cul4B in primary NPCs was then examined in
transfected cells (based on GFP expression) by immuno-
fluorescence microscopy. The analyses of these NPCs
revealed that Cul4BshRNA significantly downregulated
Cul4B compared to the control in NPCs (Figure 4B).
Since Cul4B was expressed during mitosis of the cell
cycle, we next determined if Cul4B downregulation by
shRNAs would affect cell cycle progression through the
G2/M phase of the cell cycle. The DNA content was
determined in the transfected or infected, GFP-positive
NPCs by flow cytometry after propidium iodide staining
(Figure 4C). The analyses showed that Cul4B shRNA-
expression significantly increased the number of cells in
the G2/M phase of the cell cycle. Similar trends were
observed in NT-2 cells expressing Cul4BshRNAs com-
pared to those expressing missense shRNAs (Figure 4D).
Cul4B suppression by shRNAs and expression of GFP
did not induce apoptosis since the number of apoptotic/
sub-G0/G1 cells did not increase. These data suggestcle arrest at the G2/M phase. A. Downregulation of Cul4Bs by
expressed missense shRNA. n = 3. B. Cul4B shRNA suppressed Cul4B
4BshRNA vector were identified by GFP expression. Images were
ul4BshRNA significantly downregulated Cul4B in NPCs (p < 0.04, t-Test).
y levels). C. Flow cytometric data analyses show that Cul4B
Cs. NPCs were transfected or infected with the shRNA vector (control)
om four independent experiments. Control versus shRNA-expressing cells
NT-2 cells shows that downregulation of Cul4B by Cul4BshRNA via
ycle. A representative experiment is shown. n= 3. No increase in
-2 cells or NPCs.
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through the G2/M phase of the cell cycle in both NPCs
and NT-2 cells.Cul4B-positive NPCs in nestin-GFP mice accumulated
β-catenin
Interestingly, β-catenin has been shown to accumulate
periodically in the late G2/M phase of the cell cycle and
abruptly decrease in the subsequent G1 phase in immor-
talized mouse epidermal keratinocyte MCA3D cells [39].
SVZ and SGZ are the major neurogenic niches in the
brain. To evaluate the activity of Cul4B in NPCs in vivo,
we used the nestin-GFP mouse strain that expressed GFP
under the nestin-promoter, labeling all nestin-positive
NPCs [40]. The brain sections were co-immunostained
with the antibodies against Cul4B, GFP, and β-catenin.Figure 5 Cul4B and β-catenin accumulated in the same NPCs in vivo i
subventricular zone (SVZ) and subgranular zone (SGZ) NPCs were identified
NPCs strongly expressed β-catenin. x20 objective; scale bar, 15 μm. B. Cul4B-
antibody-staining. x40 objective; scale bar, 5 μm. C. In normal human brains
cyclin E was only increased in SGZ in Cul4B-positive cells. D. TUNEL stainin
although some other cells did have. x20 objective in C and D; Blue, DAPI cou
compact layer of granule cells are visible for orientation. V, ventricle.The results showed that some NPCs expressed high
levels of both Cul4B and β-catenin in the SVZ and SGZ
(Figure 5A & B). Since β-catenin levels were high in the
same NPCs, the data suggest that the constitutive deg-
radation of β-catenin was prevented in these NPCs in
late mitosis in vivo. Although Cul4B-3 was neddylated,
the data suggest that Cul4B-3 was unable to downregu-
late β-catenin probably due to its scanty presence in
these cells. Alternatively, unneddylated Cul4Bs might
play a role in stabilizing β-catenin by forming complexes
that prevented Cul4B-3 ligase assembly and activation.Cul4B-positive cells expressed the mitotic marker MPM-2
in vivo
In vitro analyses suggest that Cul4B accumulation is ne-
cessary for NPC cell cycle progression through mitosis.n mouse and human brains. A. Using the nestin-GFP mice, the
by immunostaining with the mouse anti-GFP antibody. Cul4B-positive
expressing NPCs had the mitotic epitope as shown by the MPM-2
, Cul4B-positive cells accumulated β-catenin in both SGZ and SVZ, but
g showed that Cul4B-positive cells did not have fragmented DNA
nterstain; scale bar, 10 μm. SGZs are labeled with a bracket and a more
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in vivo, brain sections were immunostained with the
MPM-2 monoclonal antibody. The MPM-2 antibody
was originally raised against mitotic HeLa cells. It specif-
ically recognizes a cell cycle-regulated, serine/threonine-
phosphorylated epitope present in mitotic and meiotic
proteins from a wide variety of species. These proteins
become phosphorylated at the G2/M transition and are
dephosphorylated at the end of mitosis [41]. In brain
sections from one-month-old mice, Cul4B-positive cells
were also stained with the MPM-2 antibody in SGZ
(Figure 5B). These data further support the observations
that unneddylated Cul4B accumulated during mitosis.
Cul4B-positive NPCs in human brain accumulated
β-catenin and were not apoptotic
As shown in Figure 2C, some cells in the human brain
expressed a huge amount of Cul4B that co-expressed lit-
tle nedd8. We found that these Cul4B-positive cells were
mainly located in SVZ and SGZ, two major neurogenic
areas of the human brain (Figure 5C). In these cells, β-
catenin levels were very high. The accumulation of both
Cul4B and β-catenin in the same cells again suggests
that Cul4B did not downregulate β-catenin during mi-
tosis, but instead Cul4B might have stabilized β-catenin.
In the same cells, cyclin E only accumulated in NPCs in
SGZ, not in SVZ, suggesting that Cul4B might regulate
cyclin E only in SGZ.
The in vivo data suggest that the accumulation of
unneddylated Cul4B during mitosis in NPCs is a physio-
logical phenomenon. We next determined if these
Cul4B-positive cells were healthy and not undergoing
apoptosis by TUNEL staining. As shown in Figure 5D,
cells that expressed Cul4B were negative for TUNEL
staining. In contrast, some nearby Cul4B-negative epen-
dymal cells lining the ventricle were TUNEL-positive.
Thus, the Cul4B-positive cells did not have fragmented
DNA, indicating that they were not apoptotic. Together,
these data suggest that the accumulation of Cul4B dur-
ing mitosis plays a physiological role in NPC cell cycle
progression in the human brain.
Discussion
Since Cul4B mutations are associated with XLID, this
study examined the functions of the endogenous Cul4B
in NPCs and brain tissues. Through a series of
immunoprecipitation-western experiments, this study
first demonstrated that the anti-Cul4B antibody specif-
ically detected Cul4B, especially the two larger isoforms
Cul4B-1 and Cul4B-2. Further analyses demonstrated
that the two larger isoforms were unneddylated whereas
the smaller isoform Cul4B-3 was neddylated in rodent
brain protein extracts. This study showed that downre-
gulation of Cul4B in rodent NPCs or human NT-2 cellsarrested the cell cycle in the G2/M phase, suggesting
that Cul4B accumulation was necessary for cell cycle
progression through mitosis in these cells. Furthermore,
Cul4B-positive cells co-expressed the MPM-2 mitotic
epitope in brain sections, suggesting that Cul4B also
accumulated in vivo in NPCs during mitosis. Finally,
Cul4B expression was not associated with DNA frag-
mentation in vivo. Together, these data suggest that a
physiological function of Cul4B is in mitosis progression
in NPCs, which involves the accumulation of inactive
Cul4B during mitosis.
Neddylation serves as a switch for activating CRL ac-
tivity. This study demonstrated that the two larger iso-
forms of Cul4B, Cul4B-1 and Cul4B-2, were not
neddylated, which suggest that these two isoforms of
Cul4B may be inactive in downregulating substrates.
The absence of neddylation in Cul4B-1 and Cul4B-2 was
not caused by spontaneous deneddylation since the in-
hibitor, OPT, was present in the experiment. The anti-
nedd8 antibody also worked since it recognized the
smaller Cul4B-3 precipitated by the Cul4B antibody. A
recent study has shown that more Cul4B is constitu-
tively associated with the deneddylase COP9 than Cul1
[33]. Such tight association of Cul4B with COP9 may ac-
count for the absence of neddylation in Cul4B-1 and
Cul4B-2 isoforms, which we found were more abundant
in brain tissues. Despite the absence of neddylation in
Cul4B-1 and Cul4B-2, Cul4B-3 that lacked the N-
terminal portion was neddylated. In NT-2 cells and
brain tissues, DDB1 was below the detection limit in
whole protein extract. The anti-Cul4B antibody precipi-
tated very little DDB1, which on one hand suggest that
most Cul4B was not assembled with DDB1 and on the
other suggests that the co-precipitated DDB1 was prob-
ably bound to Cul4B-3. Since the major difference be-
tween Cul4B-3 and the other two isoforms was the lack
of the N-terminal sequences in Cul4B-3, the data sug-
gest that the N-terminus of Cul4B may inhibit neddyla-
tion which normally occurs in the consensus lysine
residue in the C-terminal Cullin domain. During the
preparation of this manuscript, at least two Cul4B-
knockout mouse models have been attempted but both
resulted in early embryonic lethality [42,43]. Human
mutations include C-terminal truncations or misssense
mutations, which are predicted to affect Cul4B ubiquitin
ligase activity, but null mutations are not observed.
These observations suggest the N-terminus of Cul4B
may support survival of human mutation carriers by a
mechanism involving inhibition of neddylation.
This study also showed that increased levels of Cul4B
co-existed with high levels of β-catenin in NPCs in the
neurogenic niches, SGZ and SVZ, from both rodent and
human brains. Neddylation is necessary for β-catenin
degradation since β-catenin accumulates in NPCs
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zyme Ubc12 (Chen unpublished data). There was also
little evidence that the Cul4B-expressing NPCs co-
expressed any nedd8. These data suggest that unneddy-
lated Cul4B accumulated in a particular population of
NPCs in vivo. Previous studies have shown that in the
absence of Wnt signaling, β-catenin is constitutively
downregulated via the SCF complex [44]. Furthermore,
β-catenin may be a Cul4B ligase substrate [28,29] al-
though it has not been replicated by independent labora-
tories. Together with the findings in this study, the data
suggest that Cul4B-1 and Cul4B-2 may compete with
neddylated Cul1 and possibly neddylated Cul4B-3, to
transiently inhibit the degradation of certain substrates
such as β-catenin during mitosis. In this sense, the
unneddylated Cul4B still plays an active role in mitosis
progression. It has been shown that β-catenin peaks
periodically at the G2/M phase of the cell cycle in prolif-
erating cells [45,46]. A specific function of β-catenin has
been shown to establish the bipolar mitotic spindle dur-
ing mitosis [47]. These previous studies suggest that β-
catenin is specifically protected from degradation during
mitosis, which may involve the accumulation of unned-
dylated Cul4Bs. Future studies may focus on isoform-
specific effects of Cul4B in β-catenin downregulation
when isoform-specific Cul4BshRNAs and antibodies are
available.
Why does Cul4BshRNAs arrest NPCs in G2/M phase
of the cell cycle? The Cul4BshRNAs used in this study
targeted a sequence present in all three isoforms, the
overall effect of which was to cause cell cycle arrest.
Cul4B is clearly necessary in early embryonic develop-
ment since Cul4B null mice have an embryonic lethal
phenotype [42,43], which suggests that it functions in
cell cycle progression. The current study suggests that
Cul4B not only functions in mitosis progression but
also in cell cycle withdrawal. In proliferating NPCs and
NT-2 cells, maybe all isoforms of Cul4B are necessary
for cell cycle progression, whereas in differentiating
cells, Cul4B-1 and Cul4B-2 may play a major role.
NPCs in human brains had a huge amount of Cul4B in
the cell body but very little nedd8, which suggests that
unneddylated Cul4Bs probably together with the small
amount of neddylated Cul4B-3, are necessary for mi-
tosis progression. The major supporting evidence for a
role of Cul4B in cell cycle withdrawal is that unneddy-
lated Cul4Bs were abundant in growing processes in
differentiating or G0-synchronized NT-2 cells. Future
investigations may focus on the potential isoform-
specific effects of Cul4B.
This study did not detect Cul4B in S-phase NPCs and
downregulation of Cul4B caused cell cycle arrest in G2/
M in these cells. This is in contrast to the findings in
HeLa cells where Cul4B knockdown results in S-phaseaccumulation [27]. In addition, another study shows that
silencing of Cul4B in primary MEF cells has little effect
on cell proliferation [21]. The discrepancies may be due
to cell type and methodology differences. The current
study mainly employed primary NPCs and examined en-
dogenous Cul4Bs. The BrdU labeling in the current
study lasted for only 15 min. Previous studies have also
shown that cyclin E is a Cul4B substrate, but it remains
controversial given the stimulatory role of cyclin E in S
phase progression and cell proliferation. The data from
the current study also raised questions whether Cul4B
regulates cyclin E in SVZ NPCs. The differential neddy-
lation of Cul4B isoforms as well as lack of specific anti-
bodies as we found in this study suggest that caution is
needed in interpreting the available data.
Conclusions
This study provides strong evidence that the accumula-
tion of Cul4B during mitosis is necessary for NPC cell
cycle progression through mitosis. The data suggest that
unneddylated Cul4B isoforms specifically inhibit β-
catenin degradation during mitosis. The data also show
that Cul4B-3 that misses the N-terminus present in the
other two isoforms is neddylated, suggesting that the N-
terminus may inhibit neddylation in the larger isoforms.
Furthermore, the presence of unneddylated Cul4B in
NT-2 cell processes suggests that it may have functions
other than mitosis. The huge amount of unneddylated
Cul4B in human brain hippocampal NPCs further sug-
gests that Cul4B plays a pivotal role in brain develop-
ment. These findings have opened new avenues for
future investigations, which will help understand the
cognitive deficits present in Cul4B-linked XLID.
Methods
Antibodies
Primary antibodies used in this study include rabbit
anti-Cul4B (cat# 12916-1-AP) and rabbit anti-DDB1
(Proteintech Group, Chicago, USA), mouse anti-nestin
(BD Bioscience, Sparks, MD, USA.), rabbit anti-β-
catenin and mouse anti-nedd8 (Sigma), rabbit anti-
nedd8 (Zymed), mouse anti-GFP (Antibody Inc.), mouse
anti-MPM-2 (Millipore), rabbit anti-Cul4A (Dr. Kristin
T. Chun), rabbit-anti-Cul1 (Neomarker), goat anti-β-
catenin (sc-1496), and mouse anti-cyclin E (sc-25303)
(the last two were from Santa Cruz Biotechnology, Santa
Cruz, CA, USA). The secondary antibodies conjugated
to Alexa fluor 488, Alexa fluor 564, and Alexa fluor 680
were obtained from Invitrogen (Calsbad, CA, USA).
Construct
To construct the GFP-Cul4B(1-173) fusion protein
(GFP173), the N-terminal fragment of Cul4B (1-173)
was first produced by PCR fragment using human Cul4B
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then fused to the C-terminus of GFP and cloned into
the EcoRV/Kpn1-digested pcDNA3.1/Zeo- vector (Invi-
trogen). The clone was digested and sequenced for veri-
fication. The DNA was transfected into primary NPCs
using Lipofectamine LTX (Invitrogen) according to man-
ufacturer’s protocols.Immunoprecipitation and western blotting using fresh
mouse brain tissues
Mouse brain tissues were harvested from adult C57BL/6
mice (Charles River Laboratories International). Immu-
noprecipitation and western blotting were performed
essentially as described before [37]. Briefly, freshly har-
vested mouse brains were homogenized in IP buffer con-
taining 20 mM Tris (pH 8), 1 mM MgCl2, 125 mM
NaCl, 2% CHAPS, 10% glycerol, and a mixture of prote-
ase and phosphotase inhibitors including 5 μg/ml of the
proteasome inhibitor MG132 and 1,10-orthophenathro-
line (OPT, 2 mM) [48]. The homogenate was precleared
by centrifugation and protein G sepharose 4B beads be-
fore it was incubated with the primary antibody pre-
bound to protein G sepharose 4B. The control was
incubated with protein G sepharose 4B without the anti-
body. After the immune complex was resolved on an 8-
16% precise protein gel (Pierce), the protein was trans-
ferred to nitrocellulose and blocked for 1h with 3% BSA.
The molecular weight of Cul4B proteins were as
reported in Uniprot and identified by comparing with
the Precision Plus protein standards (BioRad) on the
same blot.Primary NPC cultures
Primary NPCs were harvested from rat embryonic day
18 (E18) cerebral cortices from timed-pregnant Sprague
Dawley rats (Charles River Laboratories International,
Wilmington MA, USA). Animals were dissected accord-
ing to the protocols approved by the institutional animal
care committee. NPCs were grown as described before
[35]. Briefly, cells were initially plated as monolayers on
poly-ornithine and fibronectin-coated plates. Cells were
then used at the first or second passage after the initial
plating for flow cytometry. For cells used for immuno-
staining, the cells were initially plated to grow neuro-
spheres in non-coated dishes or monolayer in coated
dishes. The cells were subsequently plated on coated
glass-coverslips for analysis by immunostaining. In some
cases as identified in the context, primary NPCs were
grown from Day-0 C57BL/6 (Charles River) cortices by a
similar method. The only difference was that mouse cor-
tical tissue was digested with Trypsin for 1 h before cen-
trifugation and plating.NPC immunostaining
NPCs were fixed in 4% paraformaldehyde for 20 min at
room temperature. After 3 washes in PBS, cells were
treated with 2N HCl for 30 min at room temperature.
Cells were then washed and incubated in the blocking
buffer (5% BSA or normal goat serum/0.5% Triton X-
100/10 mM PBS, pH 7.4) for 15 min. Cells were incu-
bated with primary antibodies for 2 h, washed, and then
incubated with secondary antibodies for 1 h. At the end
of the antibody incubation, cells were stained with DAPI,
rinsed 5x, and mounted in 90% glycerol/PBS. Images
were taken using a 20x or 60x objective by a Nikon
Eclipse 600 or Nikon 90i epifluorescence microscope
and the program NIS-elements (Nikon). The intensity of
staining was identified by the NIS-element software.
NT-2 cells were processed similarly.
BrdU labeling of NPCs and analyses
Proliferating rat (from E18 cortices) or mouse (from Day
0 cortices) NPCs grown on coated glass coverslips were
incubated with BrdU (50 uM) for 15 min and fixed in
4% paraformaldehyde for 40 min. Cells were then immu-
nostained as described above. The analyses of Cul4B ex-
pression in BrdU-positive versus BrdU-negative mouse
NPCs were carried out using the NIS-element software
based on average density of Cul4B, which subtracted the
average background noise obtained in the same images.
The data were analyzed by t-Test assuming unequal vari-
ance (Microsoft Excel data analyses tool).
Cul4B shRNA design and downregulation in NPCs
The Cul4B shRNA targeting sequence “gataagcctaaattac
cagaa” was designed based on a previously published
siRNA sequence [36]. The targeting sequence is present
in all three isoforms of Cul4B. It was constructed in the
shRNA vector pHSVGET that we designed before
[37,38]. The difference between this protocol and our
previous one was that in the current study NPCs were
transfected with the vector that was not packaged into a
recombinant HVS-1 virus. The pHSVGET vector
allowed the expression of the shRNA under the tRNAval
promoter and the GFP protein under the CMV pro-
moter after the transfection. Since the transfection effi-
ciency was relatively low, the levels of Cul4B in the
GFP-positive cells were determined by analyzing the
microscopic images after they were taken at the same
settings using a Nikon Eclipse 600 epifluorescence
microscope and the program NIS-elements (Nikon). The
expression levels of Cul4B in 38 (control) and 47 cells
(Cul4BshRNA) were averaged and analyzed by one tail t-
Test using Excel (Microsoft).
Besides transfection, the shRNA vectors were also
packaged into HSV-1 for efficient downregulation in
NT-2 cells (ATCC) and in primary NPCs. Efficient
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unit per cell [37,38].
Flow cytometric data analyses
After NPCs were transfected for 20 h, cells were fixed in
4% paraformaldehyde for 20 min at room temperature.
Samples were washed twice in PBS and then incubated
in a buffer containing 0.02% NP40 for 1.5 h on ice while
cells were being counted. Alternatively, cells were fixed
in 70% ethanol for 5 h on ice, which we found would
not affect GFP fluorescence. After two washes in PBS,
cells were incubated with 100 μg/ml RNase A for 30
min at 37oC. Cells were then incubated overnight in a
buffer containing 10 μg/ml propidium iodide and 10 μg/
ml RNase A in PBS. The amount of the solution was
adjusted in proportion to the amount of cells in each
sample. Cells were washed twice before they were sub-
jected to flow cytometry analyses with a FACSCalibur
flow cytometer (Becton, Dickinson and Company, Frank-
lin Lakes, NJ, USA) equipped with an argon ion laser
(488 nm) for the analyses of GFP-expressing cells and a
laser with an excitation at 635 nm for PI-labeled DNA
content analyses. Transfected GFP+ cells were gated and
compared in their DNA content after propidium iodide
staining using the software ModFit LT (Version 3.0, Ver-
ity Software House, Topsham, ME, USA) as described
before [35]. Around 300 to 800 GFP-positive cells were
analyzed in these experiments. The experiment was
repeated using HSV-1-mediated expression of shRNAs
in NT-2 cells and NPCs, in which case, more than 5,000
GFP-positive cells were analyzed.
The data were analyzed by t-Test assuming unequal
variance (Microsoft Excel data analyses tool). NPC ana-
lyses were based on four independent experiments with
two from rat NPCs and two from mouse NPCs. The
analyses of NT-2 cells were based on three independent
experiments.
Nestin-GFP mice
The nestin-GFP transgenic mice were as previously
developed and characterized [40]. The brain tissue was
harvested from one month-old mice, fixed in 4% paraf-
ormaldehyde, processed for paraffin-embedding, and
sectioned in 6μm-thick sections. After dewaxing and re-
hydration, sections were incubated in 2N HCl for 30
min. Sections were then washed twice in distilled H2O
and once in PBS, and blocked and permeablized in
Blocking Buffer (5% BSA/1% Triton X-100/PBS, pH 7.4)
for 15 min. Sections were incubated in primary anti-
bodies diluted in 5% BSA/0.05% Triton X-100/PBS for 2
h. After being washed twice in 0.05% Triton, sections
were incubated with the secondary antibodies diluted in
Blocking Buffer for 1 h. Slides were immediately stained
with DAPI (10 ug/ml) for 10 min. After washing once in0.05% Triton, and three times in PBS, slides were cover-
slipped with 90% glycerol. The sections incubated in the
same buffers without the primary antibodies were used
as negative controls. Images were collected with an x40
objective using a Nikon Eclipse 600 epifluorescence
microscope.Human brain tissue immunostaining
Pre-characterized and paraffin-embedded blocks of
hippocampus from human brain samples were obtained
from Harvard Brain Bank. The postmortem brain tissues
were collected for research purposes with the approval
by Harvard research ethics committee based on NIH
guidelines and in compliance with the Helsinki Declar-
ation. After paraffin-embedded hippocampal blocks were
sectioned at 6 μm thickness. After dewaxing and rehy-
dration, the sections were incubated in 2N HCl for
30 min. The sections were then washed and blocked in
Blocking Buffer for 15 min. The sections were incubated
in primary antibodies diluted with the Blocking Buffer
for 2 h. After two washes in 0.1% Triton, the sections
were incubated with the secondary antibodies diluted in
Blocking Buffer for 1 h. The slides were immediately
stained with DAPI. To block lipofoscin, the slides were
incubated with 0.3% Sudan Black in 70% ethanol for
6 min. After washing twice in 0.5% Triton and 7x in
PBS, the slides were coverslipped with 90% glycerol. The
sections incubated in the same buffers without the pri-
mary antibodies were used as negative controls. Images
were collected with an x20 objective using a Nikon
Eclipse 600 epifluorescence microscope.TUNEL staining for DNA fragmentation
The human brain sections were processed for TUNEL
staining using a modified protocol of the ApopTag
Fluorescein In Situ Apoptosis Detection Kit (S7110,
Millipore). Briefly, after dewaxing, rehydration, HCl-
treatment, and blocking as described above, the brain
sections were equilibrated with the Equilibration Buffer
and treated with the TdT enzyme. Right after the en-
zyme reaction was stopped with the Stop/Wash Buffer,
the section was rinsed with PBS and incubated with the
anti-Cul4 antibody for 2 h at RT. After washes, the sec-
tion was incubated with the fluorescein anti-digoxigenin
conjugate (provided in the kit) and Alexa 594 goat anti-
rabbit (Invitrogen) for 1 h. Samples were then stained
with DAPI and Sudan Black as described above. A nega-
tive control was performed without the TdT enzyme
and the primary antibody.
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